Galaxy Diagnostics, Inc.

Private

North CarolinaHealthcare & Life Scienceshttps://www.galaxydx.com/

Last Round

Strategic

Jun 3, 2026

Total Funding Raised

$2.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Galaxy Diagnostics, Inc. is a biotechnology company that develops and provides advanced diagnostic tests for detecting vector-borne pathogens, such as those causing Bartonellosis and Lyme disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

tick-borne disease testingLyme disease testingBartonella testingLyme and co-infectionschronic Lyme diseasedigital PCRddPCRstealth pathogensBAPGM enrichment culturepathogen detectionBabesia testingcontract research servicesCLIA labNanotrap urine antigen testveterinary diagnosticsvector-borne disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Galaxy Diagnostics, Inc. Comps

Public and private peers based on sector, stage, and business model.

Galaxy Diagnostics, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Galaxy Diagnostics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Jun 3, 2026
Debt	Jul 10, 2024
VC Round	Jan 14, 2015
VC Round	Sep 4, 2013
Debt	Mar 5, 2013
VC Round	May 1, 2012

View all Funding Rounds

Galaxy Diagnostics, Inc. Investors

Notable investors and investment history

Galaxy Diagnostics, Inc. investors
Investor	Rounds
NIH RADx	Grant
Triangle Tweener Fund	Debt, Strategic
Ariel Savannah Angel Partners	Strategic
North Carolina Biotechnology Center	Debt
Center for Entrepreneurial Development	Strategic
Boston Harbor Angels	Debt, Strategic
Wisconsin Investment Partners	Strategic

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 3, 2026
Raised $3M in a Seed Round.
May 18, 2026
Monthly visitors increased 78% MoM, reaching 7.8K.

View all signals

Galaxy Diagnostics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Galaxy Diagnostics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Galaxy Diagnostics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNorth Carolina

Employee Range20

Year Founded2009

Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.